CV Sciences (CVSI) News Today $0.03 +0.00 (+4.90%) As of 02:47 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call TranscriptMarch 28, 2025 | insidermonkey.comQ4 2024 CV Sciences Inc Earnings CallMarch 28, 2025 | finance.yahoo.comCV Sciences targets profitability with new product lines and M&A strategy in 2025March 27, 2025 | msn.comCV Sciences, Inc. (CVSI) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comCV Sciences, Inc.: CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based FoodsMarch 27, 2025 | finanznachrichten.deCV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025March 20, 2025 | gurufocus.comCV Sciences Disputes Stock Purchase Agreement TerminationFebruary 11, 2025 | tipranks.comCV Sciences unveils Aura Collection’s THC Fizz TabletsFebruary 6, 2025 | markets.businessinsider.comHemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To KnowNovember 22, 2024 | benzinga.comCV Sciences to Acquire Extract Labs in $1.4M DealNovember 21, 2024 | marketwatch.comCV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract LabsNovember 21, 2024 | prnewswire.comCV Sciences Q3: Revenue Stable Amid New Launches, FinancingNovember 15, 2024 | benzinga.comCV Sciences Reports Q3 Revenue and Product LaunchNovember 15, 2024 | markets.businessinsider.comCV Sciences Reports Stable Q3 2024 ResultsNovember 15, 2024 | markets.businessinsider.comCV Sciences, Inc. (PNK:CVSI) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comCV Sciences, Inc. (CVSI) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comCV Sciences, Inc. Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | prnewswire.comCV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024November 8, 2024 | prnewswire.comAdvanced sampling method can track dynamic evolution of protein foldingNovember 3, 2024 | msn.comCV Sciences Inc (CVSI) Q2 2024 Earnings Call Highlights: Strategic Moves and Financial ...October 9, 2024 | finance.yahoo.comCV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free SupplementsAugust 27, 2024 | prnewswire.comHemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2August 13, 2024 | msn.comCV Sciences, Inc. (CVSI) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comCV Sciences, Inc. Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | prnewswire.comCV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024August 7, 2024 | prnewswire.comCV Sciences, Inc. (CVSI)May 15, 2024 | finance.yahoo.comCV Sciences Inc (CVSI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 15, 2024 | finance.yahoo.comHemp-Focused CV Sciences Reports Steady Q1 Revenue Amid Operational Hurdles And Acquisition Of Nutraceuticals ManufacturerMay 14, 2024 | msn.comCVSI Stock Earnings: CV Sciences Reported Results for Q1 2024May 14, 2024 | investorplace.comCV Sciences, Inc. Reports First Quarter 2024 Financial ResultsMay 14, 2024 | prnewswire.comCV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURERMay 13, 2024 | prnewswire.comCV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024May 8, 2024 | prnewswire.comCV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call TranscriptApril 1, 2024 | finance.yahoo.comCVSI Stock Earnings: CV Sciences Reported Results for Q4 2023March 28, 2024 | investorplace.comCV Sciences, Inc. Reports Fiscal Year-End 2023 Financial ResultsMarch 28, 2024 | prnewswire.comCV Sciences Inc.March 27, 2024 | wsj.comCV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet ChewsMarch 26, 2024 | finance.yahoo.comCV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024March 21, 2024 | prnewswire.comCV Sciences Stock (OTC:CVSI), Short Interest ReportFebruary 22, 2024 | benzinga.comCV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European DistributionDecember 12, 2023 | finance.yahoo.comThe Best Shampoo for Thinning Hair We Tested Is 30% Off Right NowNovember 15, 2023 | nz.finance.yahoo.comCV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comHemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%November 14, 2023 | benzinga.comCV Sciences GAAP EPS of $0.00, revenue of $4.09MNovember 14, 2023 | msn.comCV Sciences, Inc. Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comCV Sciences Inc CVSINovember 12, 2023 | morningstar.comCV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023November 9, 2023 | finance.yahoo.comCV Sciences, Inc. Launches Reserve Sleep GummiesSeptember 5, 2023 | finance.yahoo.comCV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comCV Sciences GAAP EPS of -$0.01, revenue of $4MAugust 14, 2023 | seekingalpha.com Remove Ads Get CV Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter. Email Address CVSI Media Mentions By Week CVSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVSI News Sentiment▼0.440.58▲Average Medical News Sentiment CVSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVSI Articles This Week▼50▲CVSI Articles Average Week Remove Ads Get CV Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PULM News ANVS News NAII News AYRWF News SNYR News LSB News ENLV News EGRX News LSTA News BIVI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CVSI) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CV Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CV Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
